Genpharmasec — 360° view

Genpharmasec, a company in the Trading & Distributors industry, reported revenue of ₹86 crore and net profit of ₹1.03 crore for the September 2026 quarter.

Genpharmasec (BSE: GENPHARMA) closed at ₹1.06 on 20 Nov 2026, down 32.5% over the past year. Its market capitalisation is ₹59 crore and it trades at 27.1 times earnings.

Share price
₹1.06 (20 Nov 2026)
Market cap
₹59 Cr (20 Nov 2026)
P/E
27.05 (20 Nov 2026)
Revenue
₹86 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
2.68% (FY26)
ROE
2.36% (FY26)
Book value
₹1.22 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹1.62 / ₹0.75 (20 Nov 2026)
1-year return
-32.5% (to 20 Nov 2026)
Sector
Services
Industry
Trading & Distributors
Symbol
BSE: GENPHARMA

Incorporated in 1992, Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity shares

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.